• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4602587)   Today's Articles (1972)   Subscriber (49368)
For: Basketter D, Azam P, Casati S, Corvaro M, Ezendam J, Griem P, Hubesch B, Irizar A, Kern P, Manou I, Mehling A, Rossi LH. Applying non-animal strategies for assessing skin sensitisation report from an EPAA/cefic-LRI/IFRA Europe cross sector workshop, ECHA helsinki, February 7th and 8th 2019. Regul Toxicol Pharmacol 2019;109:104477. [PMID: 31586681 DOI: 10.1016/j.yrtph.2019.104477] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2019] [Revised: 09/06/2019] [Accepted: 09/13/2019] [Indexed: 11/22/2022]
Number Cited by Other Article(s)
1
Corvaro M, Henriquez J, Settivari R, Mattson U, Forreryd A, Gradin R, Johansson H, Gehen S. GARD™skin and GARD™potency: A proof-of-concept study investigating applicability domain for agrochemical formulations. Regul Toxicol Pharmacol 2024;148:105595. [PMID: 38453128 DOI: 10.1016/j.yrtph.2024.105595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Revised: 02/19/2024] [Accepted: 02/26/2024] [Indexed: 03/09/2024]
2
Basketter DA. Risk management of skin sensitisers: A commentary. Regul Toxicol Pharmacol 2023;140:105384. [PMID: 37028500 DOI: 10.1016/j.yrtph.2023.105384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2023] [Revised: 03/10/2023] [Accepted: 03/25/2023] [Indexed: 04/09/2023]
3
Kolle SN, Flach M, Kleber M, Basketter DA, Wareing B, Mehling A, Hareng L, Watzek N, Bade S, Funk-Weyer D, Landsiedel R. Plant extracts, polymers and new approach methods: Practical experience with skin sensitization assessment. Regul Toxicol Pharmacol 2023;138:105330. [PMID: 36599391 DOI: 10.1016/j.yrtph.2022.105330] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2022] [Revised: 12/16/2022] [Accepted: 12/27/2022] [Indexed: 01/02/2023]
4
Expansion of the Cosmetics Europe skin sensitisation database with new substances and PPRA data. Regul Toxicol Pharmacol 2022;131:105169. [PMID: 35447229 DOI: 10.1016/j.yrtph.2022.105169] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2022] [Accepted: 04/13/2022] [Indexed: 11/21/2022]
5
Papadiamantis AG, Afantitis A, Tsoumanis A, Valsami-Jones E, Lynch I, Melagraki G. Computational enrichment of physicochemical data for the development of a ζ-potential read-across predictive model with Isalos Analytics Platform. NANOIMPACT 2021;22:100308. [PMID: 35559965 DOI: 10.1016/j.impact.2021.100308] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Revised: 02/01/2021] [Accepted: 03/01/2021] [Indexed: 06/15/2023]
6
Kolle SN, Landsiedel R, Natsch A. Replacing the refinement for skin sensitization testing: Considerations to the implementation of adverse outcome pathway (AOP)-based defined approaches (DA) in OECD guidelines. Regul Toxicol Pharmacol 2020;115:104713. [DOI: 10.1016/j.yrtph.2020.104713] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 06/04/2020] [Accepted: 06/07/2020] [Indexed: 12/11/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA